Anti-infectives and the Lung

Product Code: ERM75-NMEM-26041PU
  • Edited by Stefano Aliberti, James D. Chalmers and Mathias W. Pletz
    Pulmonary infections are a major cause of morbidity and mortality worldwide. Adequate and timely treatment of these infections is therefore of vital importance, especially when considering the emerging problem of antimicrobial resistance. This Monograph provides a comprehensive up-to-date overview of the use of anti-infectives in lung diseases, with chapters covering community- and hospital-acquired pneumonia, exacerbations of asthma and chronic obstructive pulmonary disease, tuberculosis and nontuberculous mycobacteria pulmonary disease, pleural infections, and fungal diseases. Other chapters address antibiotic stewardship in the community and hospital settings, and the use of antibiotics in specific patient groups (e.g. critically ill and paediatric patients). Mechanisms of action and resistance, diagnostic approaches, therapeutic options (e.g. combination therapy, dosing and routes of administration), and the development of new drugs are also discussed.

    Chapter List:
    1. Antibiotics for pulmonary infections: an overview 
    Matteo Bassetti and Elda Righi

    2. Antibiotic resistance in pulmonary infections: mechanisms and epidemiology 
    Oliwia Makarewicz, Mareike Klinger-Strobel, Ralf Ehricht, Michael Kresken and Mathias W. Pletz

    3. Antibiotics in critical care: dosing, therapeutic drug monitoring and continuous infusions 
    Maya Hites and Fabio Silvio Taccone

    4. Inhaled antibiotics in chronic airway infections 
    Felix C. Ringshausen, James D. Chalmers and Mathias W. Pletz

    5. Inhaled antibiotics in critical care 
    Charles-Edouard Luyt and Jean Chastre

    6. Identifying patients with pneumonia due to MDR organisms coming from the community 
    Marta Di Pasquale, Stefano Aliberti, Paolo Tarsia and Francesco Blasi

    7. Antibiotic stewardship in the community 
    Eleni Papakonstantinou and Daiana Stolz

    8. Antibiotic stewardship in the hospital setting 
    James D. Chalmers and Mathias W. Pletz

    9. Antibiotics in acute exacerbation of asthma and COPD 
    Gernot G.U. Rohde

    10. Antifungals in pulmonary infections: to whom, when and how? 
    Sebastian R. Ott

    11. Long-term oral antibiotic treatment: why, what, when and to whom? 
    Eva Van Braeckel and Menno M. van der Eerden

    12. Macrolide therapy for patients with pneumonia: a triple-edged sword 
    Yuichiro Shindo and Yoshinori Hasegawa

    13. Treatment options for MDR- and XDR-TB
    Kwok Chiu Chang and Giovanni Sotgiu

    14. Perspectives on antibiotic treatment of NTM pulmonary disease
    Nicolas Schönfeld

    15. Antibiotics for pleural infections
    Rahul Bhatnagar, Vasileios S. Skouras, Najib M. Rahman and Ioannis Psallidas

    16. Antibiotics in interstitial lung diseases
    Davide Biondini and Paolo Spagnolo

    17. Insights into antibiotic use in children with CAP
    Susanna Esposito, Mara Lelii, Rossana Tenconi and Maria Francesca Patria

    18. New antibiotic development for pulmonary infections: New Drugs for Bad Bugs and beyond
    Tomislav Kostyanev, Marc J.M. Bonten and Herman Goossens

    19. Combination antibiotic therapy and synergy in HAP and VAP
    Rodrigo Cavallazzi and Julio A. Ramirez
  • Delivery costs are calculated at the point of checkout.
    Delivery times (estimated) are as follows:
    UK: 2-4 business days from date of despatch. 
    Europe: 7-10 business days from date of despatch. 
    Rest of the World: 20-25 business days from date of despatch.
    Customers will be notified by email upon despatch.

Customer Reviews
Write an online review and share your thoughts with other shoppers!